A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline

BACKGROUND: Pancreatic carcinoma (PC) is an aggressive malignancy that lacks strategies for early detection. This study aimed to develop a coherent, high-throughput and non-discriminatory pipeline for the novel clinical biomarker discovery of PC. METHODS: We combined mass spectrometry (MS)-intensive...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Liu, Xiaohui, Zheng, Weimin, Wang, Wansheng, Shen, Huali, Liu, Linxiao, Lou, Wenhui, Wang, Xiaolin, Yang, Pengyuan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729477/
https://ncbi.nlm.nih.gov/pubmed/29123261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados